Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients

Else A. Aalbersberg*, Daphne M. V. Huizing, Iris Walraven, Berlinda J. de Wit-van der Veen, Harshad R. Kulkarni, Aviral Singh, Marcel P. M. Stokkel, Richard P. Baum

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1259-1265
Number of pages7
JournalJournal of Nuclear Medicine
Volume60
Issue number9
DOIs
Publication statusPublished - 1 Sep 2019

Keywords

  • DISEASE
  • EFFICACY
  • ENETS CONSENSUS GUIDELINES
  • LU-177-OCTREOTATE
  • METASTATIC NICHE
  • NEOPLASMS
  • NEUROENDOCRINE TUMORS
  • PRRT
  • TOLERABILITY
  • TRACERS
  • multivariate analysis
  • neuroendocrine tumor
  • CRITERIA

Cite this